Newstral
Ted Love
- How Dr. Ted Love Sold Sickle Cell Company To Pfizer For $5.4 BillionForbes
- 'No-win situation': Pharma trade CEO steps down after clashing with boardPOLITICO
- IPfizer is acquiring Global Blood Therapeuticsinvezz.com
- Pfizer buys blood firm for $5.4Bnwaonline.com
- Cash-rich Pfizer snaps up Global Blood Therapeutics for $5.4 billion - Mon, 08 Aug 2022 PSTThe Spokesman-Review
- BThese Companies Are Seeking a Cure for Sickle Cellbarrons.com
- Two New Drugs Help Relieve Sickle-Cell Disease. But Who Will Pay?The New York Times
- Kamala Harris Receives Donations From Big Pharma Executives Despite Claim She Rejects ThemThe Intercept
- MGlobal Blood Therapeutics shares drop after late-stage data for sickle cell disease treatmentmarketwatch.com
- Ted Love's quest for a new way to treat sickle cell disease — BioFlash podcastbizjournals.com
- Global Blood Therapeutics stock soars in first day of trading after $120M IPObizjournals.com
- Bay Area's last IPO of a slow summer set for this weekbizjournals.com
- Biotech startup Global Blood Therapeutics files for $124.2M IPObizjournals.com
- West coast biotech with former Gov. Patrick on board plans IPObizjournals.com
- 2 more startups pile on Bay Area life sciences IPO wagonbizjournals.com
- Global Blood snags $48M, leads sickle cell drug into 1st human trialbizjournals.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.